Bub3 are mutually dependent for function, and immunoprecipitation experiments demonstrated a physical association between the two. Sequence analysis of BUB] revealed a domain with similarity to protein kinases. In vitro experiments confirmed that Bubl possesses kinase activity; Bubl was able to autophosphorylate and to catalyze phosphorylation of Bub3. In addition, overproduced Bubl was found to localize to the cell nucleus.
The production of two viable and equivalent daughter cells in mitosis requires that the events leading to cell division proceed in a carefully ordered fashion. Among other tightly regulated events, replicated sister chromosomes must be properly segregated, one to each daughter cell. For this reason, mitosis cannot be allowed to proceed if the genome has not been fully replicated or if chromosomes are not properly attached to a fully assembled mitotic spindle. Mechanisms required for ensuring the dependency of cell division on completion of such prerequisite steps have been termed checkpoints (12) . The first checkpoint-associated gene product described was Rad9 (37) , which is required for delaying the cell cycle prior to mitosis for repair of damaged DNA. However, the biochemical activity of Rad9 and its precise role in enforcing normal cell cycle dependency relationships are still unclear.
In most eukaryotic cells, disruption of the spindle results in a cell cycle delay until the spindle is reassembled (5) . Treatment of wild-type yeast cells with benzimidazole-related microtubule inhibitors leads to cell cycle arrest in mitosis. Each treated cell has a large bud and replicated DNA, and the cyclical kinase activity of M-phase promoting factor (MPF) is maintained in a highly elevated state (14, 19, 20) . Inactivation of MPF and progression into subsequent phases of the cell cycle are dependent on the reassembly of microtubules.
We have previously described two mutants of the yeast Saccharomyces cerevisiae, designated bubl and bub2 mutants, which are unable to delay the cell cycle in response to loss of microtubules (14) . A third gene, BUB3, was identified as an extra-copy suppressor of the bubl-1 mutant. Like the bubl and bub2 mutants, bub3 deletion strains (bub3A) do not arrest at G2/M when treated with large doses of benzimidazole but instead continue to bud and rapidly lose viability. Three mutations with similar phenotypes, designated madl, mad2, and mad3, have been described elsewhere (20) . None of these are allelic to the bub mutations (11, 13a) . BUB2 and BUB3 have been cloned and sequenced (14) . Bub2 is closely related to the cdc16+ gene product of Schizosaccharomyces pombe (7) . The primary sequence of Bub3 is unrelated to sequences of other known proteins (14) . Neither gene is essential, although bub3 mutants grow very slowly. Here we present the cloning and characterization of BUB1, which encodes a gene product with a carboxyl-terminal domain similar to those of protein kinases. We demonstrate that Bubl autophosphorylates in vitro and provide genetic and immunological evidence that Bub3 physically interacts with and is a substrate for the Bubl kinase. We show that when overexpressed together, these proteins interfere with colony formation. Finally, we demonstrate that overproduced Bubl is directed to the nucleus.
MATERUILS AND METHODS
Yeast strains and media. The yeast strains used in these experiments were derivatives of S288C and are listed in Table  1 . The screen which yielded the bubl-1 mutation has been described, along with the construction of the bub3A::LEU2 allele (14) . Rich (YPD), minimal (SD), and sporulation media were as described elsewhere (30) . The benzimidazole compound benomyl (DuPont) was added to solid media from a 10-mg/ml stock in dimethyl sulfoxide. Concentrations to assess benomyl sensitivity were in the range of 5 to 15 jig/ml. For overexpression in galactose liquid medium, strains were transferred from fresh patches on SD lacking uracil to liquid synthetic medium lacking uracil with 2% raffinose (Sigma) as the sole carbon source. After 24 to 36 h at 260C, rapidly growing cultures were diluted to an optical density at 600 nm of 0.03, and galactose (Sigma G-0750) was added to 2%. Cultures were grown 12 to 14 h longer and then harvested. For galactose-induced overexpression on plates, fresh patches of strains on SD plates were transferred to solid synthetic medium lacking uracil with raffinose at 2% and grown for 30 h at 30°C. These strains were then transferred to synthetic agar medium with 2% galactose with various concentrations of benomyl and photographed after 3 days at 26°C. To examine inhibition of budding by microtubule disruption, MATa cells were arrested in G1 with a-factor, released onto benomyl (70 pug/ml)-containing solid medium for 6 h, and observed microscopically as described previously (14) .
DNA manipulations. A TRP1-CEN plasmid library of S. cerevisiae DNA (4a) was transformed into a bubl-l trpl-Al strain (MAY2150). Trp+ transformants were replica transferred to YPD plates containing 10 R.g of benomyl per ml.
Resistant clones were then screened for loss of the bub continued-budding-in-benomyl phenotype as described previously (14) . Plasmids from benomyl-resistant (BenR) colonies were extracted and transformed into Escherichia coli for analysis. Subcloning of the original genomic inserts to establish the boundaries of the genes was done by standard procedures. The cloned inserts could represent either the actual BUBJ locus or a suppressor locus. To distinguish between these possibilities, the ClaI-SacI region of the genomic insert from pTR37 was subcloned into the yeast integrating vector pRS306 to generate pTR50. This construct was cut with XbaI and transformed into MAY591. The resulting strain, which was BUB+, was mated to the bubl-l strain, MAY2150. When sporulated, this diploid gave rise to 16 parental ditype asci and no nonparental or tetratype asci.
Marked disruptions ofBUB1 were generated by the one-step gene replacement method (28 (18) . The major band, with an apparent molecular mass of 64 kDa as visualized by copper chloride staining, was excised and then pulverized. Immunizations of two New Zealand White rabbits, designated 1026 and 1029, were performed by HRP Inc. (Denver, Pa.) by standard methods. Serum from rabbit 1026 was used in all experiments described herein because it had a higher affinity for Bubl than that from rabbit 1029. Serum from the fourth bleed of this rabbit, designated 1026-4, was used in these experiments. Where noted, these antibodies were purified by the method of Olmsted (21) as described by Pringle et al. (27) , using the 64-kDa fusion protein from pTR124 described above. Whole cell lysate from a 500-ml culture of cells expressing the 64-kDa protein was separated by preparative SDS-PAGE for transfer to nitrocellulose. The major band as visualized by Ponceau S staining was excised and treated exactly as described previously (27) . Following elution and neutralization, antibodies were concentrated to approximately serum concentration in phosphate-buffered saline (PBS), using a Centricon (Amicon) spin filter system (molecular mass cutoff of 104 kDa).
Bub3-specific antibodies were a generous gift from Suzanne Guenette and Frank Solomon. Immunofluorescence. Cells overexpressing BUB genes as described above were sonicated briefly and then fixed for 2 h in 3.7% formaldehyde at room temperature. Fixed cells were prepared for immunofluorescence microscopy as described previously (27) and incubated overnight at 40C in 1:50-diluted affinity-pure 1026-4 primary antibodies (described above) and 1 h at room temperature with 1:250-diluted fluorescein isothiocyanate-conjugated anti-rabbit secondary antibodies.
Immunoprecipitation and autophosphorylation analysis. Immunoprecipitations were performed with affinity-purified antibodies from the fourth bleed of rabbit 1026 (1026-4) or preimmune antibodies from the same rabbit subjected to the same affinity purification regimen. In each case, a quantity of affinity-pure antibodies corresponding to 20 ,ul of untreated serum was used to immunoprecipitate Bubl from 300 to 360
[Lg of soluble yeast protein. These protein extracts were obtained from strains described above by bead beating in the cold with PBS plus a freshly added protease inhibitor cocktail including leupeptin (0.5 [Lg/ml), chymostatin (0.1 jig/ml), aprotinin (2 [ug/ml), and antipain (2.5 [Lg/ml) from a 10OX stock in water, plus pepstatin A (1 pug/ml) and phenylmethylsulfonyl fluoride (10 pLg/ml) from a 10OX stock in ethanol. Antibody incubations were performed at 40C for 3 to 5 h in PBS plus protease inhibitors (PBSPI). Immune complexes were collected by incubation at 40C for 0.5 to 1.5 h with 80 Vul of 50% protein A-Sepharose (Sigma P-3391) in PBS plus 0.1% bovine serum albumin (BSA) plus protease inhibitors (PBSBPI). Immune complexes were washed at least six times with 10 volumes of PBSBPI. An aliquot was washed at least two additional times with 10 volumes of PBSPI (no BSA) and, after boiling with 2x sample buffer, reserved for Western blot (immunoblot) analysis. The remainder was treated essentially as described previously (4) . Briefly, immune complexes were washed twice in 10 volumes of autophosphorylation buffer (50 mM Tris [pH 7.5], 10 mM MgCl2, 1% Triton X-100 [Sigma]).
The volume was reduced to 30 ,u, and 30 VLCi of [_y-32P]ATP (Amersham) was added to each. The reaction was allowed to proceed 15 min at room temperature and was then terminated by addition of 2x sample buffer and boiling. After SDS-PAGE, Coomassie blue staining, and destaining in 10% methanol-7% acetic acid-10 mM sodium pyrophosphate, radioactive bands were identified by autoradiography.
Western transfers to nitrocellulose (Schleicher & Schuell) to assess BUB1 and BUB3 overexpression and efficiency of immunoprecipitation were performed by standard methods (36) . Proteins were visualized by using the Western Light (Tropix) chemiluminescence detection kit, with the modification that 5% powdered milk was added to the blocking agent, and blots were blocked overnight at 4°C. Except where noted, Western blots were probed with unpurified antiserum diluted 500-to 1,000-fold and incubated for 1 to 2 h at room temperature or overnight at 4°C.
Nucleotide sequence accession number. The sequence of the BUB1 gene has been submitted to GenBank and assigned accession number L32027.
RESULTS
Cloning ofBUB]. BUB1 was cloned by transformation of the bubl-l strain MAY2150 with a yeast genomic library. Transformants were replica transferred to media containing 10 (Fig. 3) . When propagated, this slow-growth phenotype partially reverted, probably reflecting the accumulation of suppressing mutations. bublA cells were also supersensitive to benomyl (dead at 7.5 jig/ml, compared with 15 jig/ml for the wild type; see Fig. 5 ). Similar phenotypes were reported for bub3A mutants (14) although bub3A spores germinated with wild-type efficiency.
bub deletion mutant cells were examined for the ability to halt their budding cycles when microtubule function was compromised ( Table 2 ). Mutant and wild-type cells were synchronized in G1 with a-factor and released onto medium containing a high concentration of benomyl. After 6 h, the BUB' cells had stopped budding and arrested with a largebudded morphology (equivalent to two cell bodies in Table 2 ). In contrast, like the bubl-1 mutant (14) , both the bublA and bub3A mutants frequently produced extra buds in the presence of benomyl.
The predicted BUB] gene product has similarity to known protein kinases. The predicted 1,021-amino-acid, 118-kDa protein encoded by the BUBI gene (Fig. 2) was compared with proteins in the GenPept database, using the FASTA and BLAST programs (1, 25) . A carboxyl-terminal portion displays significant similarity to known serine-threonine protein kinases (Fig. 4) . In particular, Bubl has strong homology to kinases in the regions designated I, II, III, VI, and VII and weak homology in region IX (10) . Note that the highly conserved regions VIII and XI are not found in Bubl, and there is an MOL. CELL. BIOL. phorylate in vitro. A fusion protein including the predicted amino acids 141 to 609 of BUB1 (amino terminal to the putative kinase domain) was expressed in E. coli, purified, and injected into rabbits. Affinity-purified polyclonal antisera from these rabbits specifically recognized a group of proteins with apparent molecular masses ranging from approximately 125 to 135 kDa and several smaller proteins (Fig. 6) (Fig. 6) . These specific bands were also completely absent from cells expressing a BUB1 gene truncated by removing the two 3' PstI fragments (data not shown). Taken together, these observations indicate that these antibodies specifically recognize cellular forms of Bubl. The affinity-pure antibodies were used to immunoprecipitate Bubl from extracts made from overproducing cells. These precipitates were Western blotted and probed with the same antibodies. Only bands corresponding to 125 and 130 kDa were observed, although the dense band caused by the precipitating antibody heavy chains might have obscured forms near 50 kDa (Fig. 7 and 8 and data not shown). It is likely that the other molecular mass forms of Bubl visible in the Fig. 6 Western blot are proteolytic fragments or other short-lived forms.
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These antibodies were used to immunoprecipitate overproduced Bubl from the soluble portion of whole cell lysates. One-third of the immune complex sample was incubated in a buffer containing MgCl2 and [y-32P]ATP and then subjected to SDS-PAGE and autoradiography (Fig. 7) . The remaining two-thirds were subjected to SDS-PAGE, then blotted to nitrocellulose, and probed with antibodies to Bubl. The autophos- Strains were derepressed on synthetic media with raffinose and then plated to glucose or galactose medium containing the concentration of benomyl (in micrograms per milliliter) indicated at the bottom (see Materials and Methods for details of plasmid construction and growth conditions). For each horizontal row of cells, the chromosomal genotype is indicated followed by the relevant plasmid-borne genes. pGAL indicates that the following gene is expressed from a galactose-inducible promoter. Note that both galactose promoter-driven BUB1 and BUB3 express sufficient gene product on glucose medium to cause phenotypic consequences. All plasmids have the URA3 marker. pBUB3 is a CEN vector, but all other plasmids are multicopy 2pum vectors derived from YEp352. Strains: bubl-1 YEp352, MAY3419; bubl-] pBUB3, MAY1800; bubl-1 pGAL-BUBJ, MAY3421; bublA YEp352, MAY3337; bublA pBUB3, MAY3420; bublA pGAL-BUB3, MAY3339; bub3A YEp352, MAY3343; bub3A pGAL-BUBJ, MAY3316; bub3A pGAL-BUB3, MAY3340; BUB' YEp352, MAY3317; BUB' pGAL-BUBJ, MAY3335; BUB' pGAL-BUB3, MAY3341; BUB' pGAL-BUBJ pGAL-BUB3, MAY3188; BUB+ pGAL-bublK733R pGAL-BUB3, MAY3275; bubl-1 pGALbubJK733R, MAY3422; bublA pGAL-bublK733R, MAY3423. phorylation experiment revealed a major phosphate-labeled band of approximately 130 kDa. In the parallel immunological detection experiment, anti-Bubl antibodies detect a doublet of proteins corresponding to molecular masses of 125 and 130 kDa. No bands of this size were observed in either experiment when preimmune serum was substituted for immune serum in the immunoprecipitation. Furthermore, none of these bands were observed unless BUB1 was overexpressed in the cells from which the extracts were made. Therefore, we conclude that 130-kDa phosphoprotein and the immunologically detected doublet represent forms of the authentic BUB1 gene product.
Since it was possible that the observed phosphorylation of Bubl was catalyzed by a contaminating protein kinase, the experiment was also performed with the bublK733R mutant described above. When the mutant allele was overexpressed, it produced a protein of the size of Bubl that was visible by Western analysis. No significant incorporation of 32p was observed for this protein (Fig. 7A, lane 4) . Note that in some experiments with this mutant, a very faint band was observed at the molecular mass of Bubi (data not shown). This weak signal may be due to the presence of a contaminating protein kinase in the immunoprecipitate or possible low residual activity of the mutant gene product. Although the lysine-to-arginine substitution is highly conservative, it appears to reduce the stability of the protein, and consequently a smaller amount mutant protein was immunoprecipitated from an equivalent amount of cell lysate. To compensate for this in the experiment, a portion of the wild-type Bubl complexes was diluted fivefold and analyzed next to the bublK733R mutant. Even in the diluted wild-type lane (Fig. 7A, lane 3) , 32p incorporation was much higher than for the bublK733R mutant. These data indicate that Bubl exhibits protein kinase activity in vitro.
Bub3 physically interacts with and is a substrate for the Bubl protein kinase in vitro. Several smaller proteins, ranging from approximately 30 to 90 kDa, were also phosphate labeled in the Bubi immunoprecipitates ( Fig. 7A and 8A ). These could represent other coimmunoprecipitating substrates, degraded forms of phosphorylated Bubl, or even phosphorylated antibody chains. Since Bub3 has a predicted molecular mass of 39 kDa, we tested the hypothesis that the 40-kDa protein prominently labeled in the precipitates represented the BUB3 gene product. Although the 40-kDa protein band could sometimes be seen when BUB3 was expressed from its chromosomal promoter, the band increased in intensity when BUB3 was overexpressed along with BUB1 (Fig. 8A) . When the autophosphorylation assay was performed with extracts from bub3 deletion mutants overexpressing BUB1, the 40-kDa band was absent. Furthermore, a protein of the same molecular mass was recognized by Bub3 antibodies in Bubl immunoprecipitates ( Fig. 7B and 8B ). We conclude from these observations that Bubl and Bub3 coimmunoprecipitate and that the BUB3 gene product is an in vitro substrate for Bubl.
Overexpression of BUB3 along with BUB1 resulted in a consistently higher level of labeling of all proteins phosphorylated in the experiment compared with overproduction of Bubl alone (Fig. 8A, lane 1 (Fig. 8B) . However, autophosphorylation of Bubl did not depend on the presence of Bub3 in the cell extract; Bubl phosphorylation was still observed when it was immunoprecipitated from a bub3 deletion mutant (Fig. 8A, lane 3) . These data suggest that Bub3 has an activating effect on the Bubl kinase but is not essential for its (14) . Several lines of evidence suggested that Bubl and Bub3 act as part of a single pathway to maintain normal cell cycle timing. First, BUB3 was originally cloned as an extra-copy suppressor of bubl-J. Second, the phenotypes of the bublA bub3A double-deletion mutant were similar or equivalent to those of either single mutant. These mutants were viable but extremely slowly growing and sensitive to benomyl. Third, overexpression of the two genes together led to a sharp reduction in growth rate, although overproduction of the single gene products did not inhibit growth under permissive conditions. Fourth, these genes are each capable of allele-specific suppression of the tubl-729 mutation when present in extra copy (9) . Despite this genetic link, there is still no direct evidence for interaction of either Bubl or Bub3 with tubulin. Finally, the two proteins coimmunoprecipitated, and the presence of Bub3 seemed to increase the in vitro activity of the Bubl kinase.
The phenotypes of bubl and mad3 mutants are similar (14, 20) . Both exhibit premature cell cycle progression when the function of the mitotic spindle is compromised. The recently determined sequence of MAD3 revealed that the predicted amino terminus of its product is closely related to the amino terminus of Bubl (11) . The first 360 amino acids of Bubl are 35% identical to the corresponding region of Mad3, and this region includes a 147-amino-acid sequence that is 44% identical. This region overlaps with the region of Bubl that we found is sufficient to interact with Bub3 in vitro (amino acids 141 through 609), suggesting the possibility that Mad3 also binds Bub3. Protein kinase consensus sequences were not found in the predicted AMD3 gene product.
Bubl and Bub3 activities are required to prevent premature exit from M phase when mitotic spindle function is compromised by microtubule depolymerization (14) . It is possible that under these conditions, the Bubl kinase is activated in some sort of signal transduction capacity. We have been unable to detect any difference in Bubl kinase activity between extracts obtained from nocodazole-treated and untreated cells (unpublished observations). However, it is possible that the overproduction of Bubl necessary for its detection in this experiment overshadowed any normal in vivo regulatory effects. We can suggest two potential mechanisms of catalytic regulation of the Bubl kinase. First, Bubl is a member of a small subset of protein kinases with a tyrosine residue in the ATP binding site corresponding to position 716 in Bubl. Most of the other members of this group are closely related to p34cdc2, the catalytic subunit of the MPF kinase (10) . In some eukaryotes, MPF kinase activity is negatively regulated by phosphorylation of this tyrosine (3, (22) (23) (24) Elimination of MPF activity has been suggested to be required for exit from mitosis (8, 35) . Since MPF activity has been shown to be improperly regulated in the bub mutants (14) , the various MPF subunits may reasonably be viewed as candidate substrates and/or downstream effectors for Bubl and Bub3. Many of the cyclin subunits of MPF are known to be phosphorylated in vivo. Although phosphorylation of Xenopus B-type cyclins has been shown to be nonessential for normal cell cycle function (15), a role for their phosphorylation in checkpoint control has not been ruled out.
In S. pombe, negative regulation of MPF activity is achieved in part through the phosphorylation of p34cdc2 on tyrosine 15 and threonine 14 (3, (22) (23) (24) . Although the equivalent residues are phosphorylated with similar cell cycle kinetics on the S. cerevisiae homolog Cdc28 (2, 34), these phosphorylations are dispensable for normal arrest in G1, S, or M phase. Indeed, mutations causing the change of the threonine and tyrosine to nonphosphorylatable residues has no influence on cell cycle timing or cell viability. In light of the deleterious nature of bubl or bub3 mutations and their negative influence on MPF activity (14) , it is unlikely that this Bub pathway influences cycle timing by affecting the phosphorylation state of these residues. In S. pombe, as well as other eukaryotes, the p40MOJS kinase is believed to catalyze phosphorylation of a third site on p34cdc2 (equivalent to S. cerevisiae position Thr-160), an event required for its activation (6, 26, 33 
